Smooth muscle cell gene expression controls the development and fate of vascular and non-vascular smooth muscle cells. In adult vascular smooth muscle cells (VSMC), the pattern of gene expression determines whether the cells exist in a contractile phenotype that is responsible for the control of vascular tone, or in a synthetic phenotype that is responsible for the repair of vessels in response to injury. The mechanism of VSMC-specific gene expression is a subject of interest since an understanding of the molecular control of this process may lead to a better understanding of the genesis of vascular disorders. One VSMC-specific transcriptional mechanism that has been defined is the serum response factor (SRF)-myocardin dependent regulation of VSMC-specific gene promoters. SRF-myocardin dependent gene regulation is modulated by many factors including the Ternary Factor Complex protein, Elk-1. Elk-1 is regulated by cellular signaling pathways such as growth factor-dependent phosphorylation and the small ubiquitin-like modifier protein (SUMO). Post-translational modification of Elk-1 by phosphorylation and sumoylation have been shown to alter SRF nuclear import and SRF-myocardin dependent mRNA expression. Likewise, the RhoA-Rho kinase signaling is also important for VSMC-specific gene expression because the RhoA pathway is involved in nuclear import of SRF. The nitric oxide (NO)-cGMP pathway stimulates VSMC-specific gene expression. Our laboratory has shown that the downstream mediator of NO-cGMP signaling, cGMP-dependent protein kinase (PKG), stimulates VSMC-specific gene expression but the mechanisms are undefined. We have obtained preliminary evidence that indicates that PKG stimulates sumoylation of Elk-1 in VSMC, and several laboratories have suggested that NO-cGMP signaling may be involved in the regulation of the RhoA-Rho kinase pathway. Both effects of PKG, Elk-1 SUMOylation and RhoA signaling, may shed light on the mechanism by which NO signaling increases VSMC-specific gene expression. This proposal is a basic science investigation to define the possible mechanisms by which PKG regulates VSMC-specific gene expression. The hypothesis is that PKG stimulates Elk-1 sumoylation, an effect which de-represses the action of Elk-1 on SRF/myocardin-dependent gene expression, and enhances RhoA signaling in cultured VSMC. These effects, in turn, stimulate SRF nuclear import and SRF-myocardin stimulated gene expression leading the cells to assume a contractile phenotype.
The specific aims are to (1) determine the mechanism by which PKG increases SRF-dependent transcription via regulation of Elk-1 in rat aortic VSMC, and (2) to determine the mechanism by which PKG interacts with RhoA signaling to stimulate SRF-dependent gene expression. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053426-10
Application #
7114383
Study Section
Special Emphasis Panel (ZRG1-CVS-F (02))
Program Officer
Rabadan-Diehl, Cristina
Project Start
1995-07-01
Project End
2010-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
10
Fiscal Year
2006
Total Cost
$249,496
Indirect Cost
Name
University of South Alabama
Department
Physiology
Type
Schools of Medicine
DUNS #
172750234
City
Mobile
State
AL
Country
United States
Zip Code
36688
Chettimada, Sukrutha; Rawat, Dhwajbahadur K; Dey, Nupur et al. (2012) Glc-6-PD and PKG contribute to hypoxia-induced decrease in smooth muscle cell contractile phenotype proteins in pulmonary artery. Am J Physiol Lung Cell Mol Physiol 303:L64-74
Choi, ChungSik; Sellak, Hassan; Brown, Felricia M et al. (2010) cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation. Am J Physiol Heart Circ Physiol 299:H1660-70
Wang, Shuxia; Lincoln, Thomas M; Murphy-Ullrich, Joanne E (2010) Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta} activity in vascular smooth muscle cells. Am J Physiol Cell Physiol 298:C1188-97
Lincoln, Thomas M (2007) Myosin phosphatase regulatory pathways: different functions or redundant functions? Circ Res 100:10-2
Browner, Natasha C; Dey, Nupur B; Bloch, Kenneth D et al. (2004) Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J Biol Chem 279:46631-6
Browner, Natasha C; Sellak, Hassan; Lincoln, Thomas M (2004) Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells. Am J Physiol Cell Physiol 287:C88-96
Stegemann, Jan P; Dey, Nupur B; Lincoln, Thomas M et al. (2004) Genetic modification of smooth muscle cells to control phenotype and function in vascular tissue engineering. Tissue Eng 10:189-99
Wang, Shuxia; Wu, Xing; Lincoln, Thomas M et al. (2003) Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-beta activity. Diabetes 52:2144-50
Brophy, Colleen M; Woodrum, David A; Pollock, Jennifer et al. (2002) cGMP-dependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J Vasc Res 39:95-103
Anderson, P G; Boerth, N J; Liu, M et al. (2000) Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury. Arterioscler Thromb Vasc Biol 20:2192-7

Showing the most recent 10 out of 14 publications